Financials

OMGAQ fundamentals

An in-depth look to Omega Therapeutics, Inc. operating, investing, and financing activities

OMGAQ free cash flow for Q3 24 is -14.03 M USD. For 2023, OMGAQ free cash flow was -94.38 M USD and operating cash flow was -91.51 M USD.

Q1 '20

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: USD